# Vascular & Bone Disorders — GCMD Library living collection

Updated: n/a · 2 episodes · 10 cited statements

## Episodes
### Infantile Hemangiomas
- [Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome](https://library.globalcastmd.com/article/treatment-of-infantile-hemangiomas-with-sirolimus-in-a-patient-with-phace-syndro-17042) — article · [machine version](https://library.globalcastmd.com/article/treatment-of-infantile-hemangiomas-with-sirolimus-in-a-patient-with-phace-syndro-17042.md)

### Gorham-Stout Disease
- [Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy](https://library.globalcastmd.com/article/gorham-stout-disease-successfully-treated-with-sirolimus-and-zoledronic-acid-the-17031) — article · [machine version](https://library.globalcastmd.com/article/gorham-stout-disease-successfully-treated-with-sirolimus-and-zoledronic-acid-the-17031.md)

## Statements
Every statement is attributed, typed, and timestamped; the link is the citation.
- Gorham-Stout disease is a life-threatening disorder often manifested by lymphatic malformation and osteolysis. (established) (no timestamp yet)
- Available therapies for Gorham-Stout disease are not uniformly effective and often carry substantial morbidity. (established) (no timestamp yet)
- An 18-year-old male with Gorham-Stout disease manifested by lytic rib lesions and intractable pleural effusion responded dramatically to combination therapy with sirolimus and zoledronic acid after failing interferon therapy. (research) (no timestamp yet)
- The combination of sirolimus and zoledronic acid has demonstrated synergism in preclinical cancer models. (research) (no timestamp yet)
- Infantile hemangiomas are common benign tumors of childhood. (established) (no timestamp yet)
- Infantile hemangiomas often regress satisfactorily without intervention. (established) (no timestamp yet)
- A subset of infantile hemangiomas may lead to functional or cosmetic morbidity necessitating therapy. (established) (no timestamp yet)
- PHACE syndrome is characterized by a variety of neurocutaneous and vascular anomalies that typically include segmental hemangiomas. (established) (no timestamp yet)
- Treatment with sirolimus provided benefit with regression of the cutaneous infantile hemangioma in a patient with PHACE syndrome who failed conventional first-line therapies. (research) (no timestamp yet)
- Sirolimus is an inhibitor of the mammalian target of rapamycin (mTOR) pathway. (established) (no timestamp yet)

---
Educational content from recorded physician discussions — not medical advice. Cite the canonical URL or the ?t= deep link. Policy: https://library.globalcastmd.com/ai
